FDA DrugClass II

Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-274-01

Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.

From the FDA notice · Read the official notice ↗ · All Lupin recalls

What to do

The agency's notice has the remedy and who to contact.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-274-01
Sold in
FL, MA, MI & OH
Made for
Adults (0 months and older)

Details

Units affected
32736 vials
Illnesses reported
None reported
Manufactured in
5801 Pelican Bay Blvd, Suite 500, Naples, FL, United States
Classification
Class II
Recall number
D-0220-2026

In the FDA's words

Description
Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-274-01 Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity. Lot #: WB00006, Exp 12/31/2026 Distribution: FL, MA, MI & OH Affected quantity: 32736 vials
Hazard
Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.

More from Lupin

See all

Related topics

Industrial chemicalsOtherDrugsFLMAMIOHMore from FDA Drug